Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
13
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Shiff Susan Ph.D. | Director | 2 | $0 | $0 | 2026-06-09 |
| HALL WALLACE L JR | Director | 6 | $0 | $0 | 2026-06-09 |
| Smith Cynthia | Director | 2 | $0 | $0 | 2026-06-09 |
| Shah Sujal | Director | 4 | $0 | $0 | 2026-06-09 |
| WYZGA MICHAEL S | Director | 3 | $0 | $0 | 2026-06-09 |
| Conn Avi Daniel | Chief Financial Officer | 4 | $0 | $0 | 2026-01-29 |
| O'Brien Stephen Paul | Principal Accounting Officer | 5 | $0 | $0 | 2026-01-29 |
| Alibhai Imran Nizamudin | Chief Executive Officer | 6 | $0 | $0 | 2026-01-29 |
| Kauh John Saewook M.D. | Chief Medical Officer | 4 | $0 | $0 | 2026-01-29 |
| Tweardy Samuel David | 10% Owner | 2 | $0 | $0 | 2025-07-07 |
| Chen Yixin | VP, Chem, Mfg and Ctrls | 2 | $0 | $0 | 2025-04-17 |
| Larson Jeffrey Leroy | SVP, Research & Development | 3 | $0 | $0 | 2025-04-17 |
| Wirk Shaheen | Director | 7 | $0 | $0 | 2025-04-17 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Shah Sujal | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Smith Cynthia | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Shiff Susan Ph.D. | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 6,000 | — | $0 | 6,000 | SEC↗ |
| WYZGA MICHAEL S | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 6,000 | — | $0 | 6,000 | SEC↗ |
| HALL WALLACE L JR | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Alibhai Imran Nizamudin | Chief Executive Officer | A Award deriv | 2026-01-29 | 2026-02-02 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Kauh John Saewook M.D. | Chief Medical Officer | A Award deriv | 2026-01-29 | 2026-02-02 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Conn Avi Daniel | Chief Financial Officer | A Award deriv | 2026-01-29 | 2026-02-02 | 45,000 | — | $0 | 45,000 | SEC↗ |
| O'Brien Stephen Paul | Principal Accounting Officer | A Award deriv | 2026-01-29 | 2026-02-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Alibhai Imran Nizamudin | Chief Executive Officer | A Award deriv | 2025-12-16 | 2025-12-18 | 47,500 | — | $0 | 47,500 | SEC↗ |
| Conn Avi Daniel | Chief Financial Officer | A Award deriv | 2025-12-16 | 2025-12-18 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Kauh John Saewook M.D. | Chief Medical Officer | A Award deriv | 2025-12-16 | 2025-12-18 | 17,500 | — | $0 | 17,500 | SEC↗ |
| O'Brien Stephen Paul | Principal Accounting Officer | A Award deriv | 2025-12-16 | 2025-12-18 | 4,000 | — | $0 | 4,000 | SEC↗ |
| Tweardy Samuel David | 10% Owner | J Other | 2025-07-07 | 2025-08-05 | 315,658 | — | $0 | 0 | SEC↗ |
| Tweardy Samuel David | 10% Owner | J Other | 2025-07-07 | 2025-08-05 | 315,658 | — | $0 | 0 | SEC↗ |
| HALL WALLACE L JR | Director | A Award deriv | 2025-04-17 | 2025-04-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Shah Sujal | Director | A Award deriv | 2025-04-17 | 2025-04-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Smith Cynthia | Director | A Award deriv | 2025-04-17 | 2025-04-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| WYZGA MICHAEL S | Director | A Award deriv | 2025-04-17 | 2025-04-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Wirk Shaheen | Director | A Award deriv | 2025-04-17 | 2025-04-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Shiff Susan Ph.D. | Director | A Award deriv | 2025-04-17 | 2025-04-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Alibhai Imran Nizamudin | Chief Executive Officer | A Award deriv | 2025-04-17 | 2025-04-21 | 182,320 | — | $0 | 182,320 | SEC↗ |
| Kauh John Saewook M.D. | Chief Medical Officer | A Award deriv | 2025-04-17 | 2025-04-21 | 36,210 | — | $0 | 36,210 | SEC↗ |
| Conn Avi Daniel | Chief Financial Officer | A Award deriv | 2025-04-17 | 2025-04-21 | 43,547 | — | $0 | 43,547 | SEC↗ |
| Chen Yixin | VP, Chem, Mfg and Ctrls | A Award deriv | 2025-04-17 | 2025-04-21 | 7,213 | — | $0 | 7,213 | SEC↗ |
| O'Brien Stephen Paul | Principal Accounting Officer | A Award deriv | 2025-04-17 | 2025-04-21 | 7,213 | — | $0 | 7,213 | SEC↗ |
| Larson Jeffrey Leroy | SVP, Research & Development | A Award deriv | 2025-04-17 | 2025-04-21 | 10,820 | — | $0 | 10,820 | SEC↗ |
| Alibhai Imran Nizamudin | Chief Executive Officer | A Award deriv | 2025-04-15 | 2025-04-17 | 207,881 | — | $0 | 207,881 | SEC↗ |
| Alibhai Imran Nizamudin | Chief Executive Officer | A Award deriv | 2025-04-15 | 2025-04-17 | 160,940 | — | $0 | 160,940 | SEC↗ |
| Alibhai Imran Nizamudin | Chief Executive Officer | A Award deriv | 2025-04-15 | 2025-04-17 | 2,011 | — | $0 | 2,011 | SEC↗ |
| Conn Avi Daniel | Chief Financial Officer | A Award deriv | 2025-04-15 | 2025-04-17 | 89,053 | — | $0 | 89,053 | SEC↗ |
| Larson Jeffrey Leroy | SVP, Research & Development | A Award deriv | 2025-04-15 | 2025-04-17 | 5,364 | — | $0 | 5,364 | SEC↗ |
| Larson Jeffrey Leroy | SVP, Research & Development | A Award deriv | 2025-04-15 | 2025-04-17 | 16,764 | — | $0 | 16,764 | SEC↗ |
| Shah Sujal | Director | A Award deriv | 2025-04-15 | 2025-04-17 | 10,394 | — | $0 | 10,394 | SEC↗ |
| Shah Sujal | Director | A Award deriv | 2025-04-15 | 2025-04-17 | 8,047 | — | $0 | 8,047 | SEC↗ |
| Wirk Shaheen | Director | A Award deriv | 2025-04-15 | 2025-04-17 | 2,011 | — | $0 | 2,011 | SEC↗ |
| Chen Yixin | VP, Chem, Mfg and Ctrls | A Award deriv | 2025-04-15 | 2025-04-17 | 14,752 | — | $0 | 14,752 | SEC↗ |
| WYZGA MICHAEL S | Director | A Award deriv | 2025-04-15 | 2025-04-17 | 18,441 | — | $0 | 18,441 | SEC↗ |
| Kauh John Saewook M.D. | Chief Medical Officer | A Award deriv | 2025-04-15 | 2025-04-17 | 74,049 | — | $0 | 74,049 | SEC↗ |
| O'Brien Stephen Paul | Principal Accounting Officer | A Award deriv | 2025-04-15 | 2025-04-17 | 3,352 | — | $0 | 3,352 | SEC↗ |
| O'Brien Stephen Paul | Principal Accounting Officer | A Award deriv | 2025-04-15 | 2025-04-17 | 11,399 | — | $0 | 11,399 | SEC↗ |
| Wirk Shaheen | Director | J Other | 2025-04-15 | 2025-04-17 | 176,030 | — | $0 | 176,030 | SEC↗ |
| Wirk Shaheen | Director | J Other | 2025-04-15 | 2025-04-17 | 263,164 | — | $0 | 263,164 | SEC↗ |
| Wirk Shaheen | Director | A Award | 2025-04-15 | 2025-04-17 | 4,191 | — | $0 | 4,191 | SEC↗ |
| HALL WALLACE L JR | Director | J Other | 2025-04-15 | 2025-04-17 | 44,712 | — | $0 | 44,712 | SEC↗ |
| HALL WALLACE L JR | Director | J Other | 2025-04-15 | 2025-04-17 | 202,044 | — | $0 | 202,044 | SEC↗ |
| Wirk Shaheen | Director | A Award | 2025-04-15 | 2025-05-02 | 176,030 | — | $0 | 176,030 | SEC↗ |
| Wirk Shaheen | Director | A Award | 2025-04-15 | 2025-05-02 | 263,164 | — | $0 | 263,164 | SEC↗ |
| HALL WALLACE L JR | Director | A Award | 2025-04-15 | 2025-05-02 | 202,044 | — | $0 | 202,044 | SEC↗ |
| HALL WALLACE L JR | Director | A Award | 2025-04-15 | 2025-05-02 | 44,712 | — | $0 | 44,712 | SEC↗ |